MANAC Chemical PartnersMANAC Chemical Partners Co.,Ltd.4360東証スタンダード化学FY ending Mar 2026, consolidated, J-GAAP

MANAC Chemical Partners FY ending Mar 2026 results

About 46% of MANAC Chemical Partners's sales come from Fine chemical business, with Flame retardants business and Health support business making up much of the rest.

Out of every ¥100 of sales, about ¥7 is left as operating profit.

Revenue changed +18.2% from the prior year, and it swung back to an operating profit.

Revenue and profit pattern

Turned profitable

What changed from last year

FY ending Mar 2025 → FY ending Mar 2026

Revenue
+18.2%¥9.3B → ¥11B
Gross profit
+69.9%¥1.47B → ¥2.5B
Operating income
Back to profit-¥342M → ¥739M
Net income attributable to owners
Back to profit-¥895M → ¥781M
Operating cash flow
+1888.0%¥108M → ¥2.15B
Free cash flow
Back to profit-¥411M → ¥523M

Where the money goes

FY ending Mar 2025 → FY ending Mar 2026

Where ¥100 of sales goes

For every ¥100 MANAC Chemical Partners sells, how much goes where, and how much is kept.

FY ending Mar 2026
Cost of sales
¥77
SG&A
¥16
Operating profit
¥7
Net profit kept
¥7

Annual margin trends

Gross margin22.8%
FY ending Mar 2022: 22.7%22.7%FY ending Mar 2023: 23.7%23.7%FY ending Mar 2024: 18.8%18.8%FY ending Mar 2025: 15.8%15.8%FY ending Mar 2026: 22.8%22.8%FY22FY23FY24FY25FY26
Operating margin6.7%
FY ending Mar 2022: 6.9%6.9%FY ending Mar 2023: 8.4%8.4%FY ending Mar 2024: -1.1%-1.1%FY ending Mar 2025: -3.7%-3.7%FY ending Mar 2026: 6.7%6.7%FY22FY23FY24FY25FY26
Net margin7.1%
FY ending Mar 2022: 6.7%6.7%FY ending Mar 2023: 6.9%6.9%FY ending Mar 2024: 0.8%0.8%FY ending Mar 2025: -9.6%-9.6%FY ending Mar 2026: 7.1%7.1%FY22FY23FY24FY25FY26

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Which businesses earn the money

Revenue by business segment, and the profit each one keeps.

FY ending Mar 2026

Profit by segment

※ Segment figures include inter-segment sales and do not sum to the company total

Sources

Show source documents (5)
  • EDINET (FSA Japan)

    有価証券報告書-第5期(2025/04/01-2026/03/31)

    ID S100YGOW2026-06-26Open
  • EDINET (FSA Japan)

    有価証券報告書-第4期(2024/04/01-2025/03/31)

    ID S100VYLQ2025-06-25Open
  • EDINET (FSA Japan)

    有価証券報告書-第3期(2023/04/01-2024/03/31)

    ID S100TJRW2024-06-28Open
  • EDINET (FSA Japan)

    有価証券報告書-第2期(2022/04/01-2023/03/31)

    ID S100R3ZN2023-06-30Open
  • EDINET (FSA Japan)

    有価証券報告書-第1期(令和3年4月1日-令和4年3月31日)

    ID S100O90G2022-06-24Open

Extracted from XBRL: 51 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.